Table 2.
Univariate and multivariate analysis for disease-free survival and overall survival in HCC patients
| Characteristics | Univariate analysis | Multivariate analysis | ||||||
|---|---|---|---|---|---|---|---|---|
| Disease-free survival | Overall survival | Disease-free survival | Overall survival | |||||
| HR | 95% CI P value |
HR | 95% CI P value |
HR | 95% CI P value |
HR | 95% CI P value |
|
| Age ≤ 40 | 2.2 |
1.2–2.8 < 0.01 |
2.1 | 1.4–2.6 < 0.01 | 1.8 | 1.1–3.1 < 0.01 | 2.3 | 1.3–3.2 < 0.01 |
| AFP ≥ 100 ng/dL | 1.2 |
1.1–2.1 < 0.05 |
1.6 |
1.2–2.4 < 0.05 |
1.9 |
1.2–3.1 < 0.05 |
||
| Sex male | 0.3 | NS | 0.4 | NS | ||||
| HBV-positive | 0.5 | NS | 0.6 | NS | ||||
| BMI ≥ 23 | 0.4 | NS | 0.3 | NS | ||||
| Family history cancers | 0.8 | NS | 0.7 | NS | ||||
| Maximum tumor size > 5 cm | 1.8 |
1.2–3.1 < 0.01 |
1.6 |
1.2–3.4 < 0.01 |
2.1 |
12–4.1 < 0.01 |
1.8 |
1.3–3.5 < 0.01 |
| Multiple tumors | 0.6 | NS | 0.4 | NS | ||||
| Microvascular invasion | 0.6 | NS | 0.8 | NS | ||||
| Portal vein invasion | 2.5 |
1.2–4.3 < 0.01 |
2.0 |
1.3–3.9 < 0.01 |
3.1 |
1.9–4.2 P < 0.01 |
2.2 |
1.3–3.4 P < 0.01 |
| Satellite nodules | 1.8 |
1.1–2.7 < 0.05 |
1.2 |
1.1–2.9 < 0.05 |
1.4 |
1.2–2.9 < 0.05 |
||
| Edmondson grade | 0.5 | NS | 0.3 | NS | ||||
| Tumor capsule formation | 0.4 |
0.1–08 < 0.05 |
0.6 |
0.2–0.9 < 0.05 |
0.5 |
0.1–0.8 < 0.05 |
0.7 |
0.1–0.9 < 0.05 |
| Hepatic capsule invasion | 0.3 | NS | 0.1 | NS | ||||
| Microvascular tumor emboli | 0.4 | NS | 0.2 | NS | ||||
| TNM stage | 3.1 |
1.8–4.9 < 0.01 |
2.2 |
1.5–3.6 < 0.01 |
3.0 |
1.3–4.3 < 0.01 |
2.1 |
1.5–3.9 < 0.01 |
| Resection margin < 1 cm | 0.7 | NS | 0.4 | NS | ||||
NS not significant